DMO

Question 1

What are the NICE criteria for treatment?

Answer 1

CRT >400 um

Question 2

What is the usual Eylea regime for DMO?

Answer 2

5 x monthly Eylea

3 x two monthly Eylea

Question 3

What is the DMO regime using Lucentis?

Answer 3

Monthly injections until oct is dry and v/a stable for two visits then extend.

Question 4

If a patient has DMO and it is not affecting the vision what is the course of action?

Answer 4

Consider improving diabetic control first - discuss with patient.

Question 5

If a pseudoaphakic patient has their vision impaired due to DMO what treatments are suitable?

Answer 5

Ozurdex may be suitable if patient has not responded to non-corticosteroid treatment and may only require re-injection every six months or anti-VEGF.

Question 6

What is iluvien and when would it be used?

Answer 6

It is a steroid slow release implant that can last up to 3 years. Useful in patients who have not responded to anything else, are pseudoaphakic and are not know steroid responders!